Amesite Inc. has announced a significant new enterprise agreement for its NurseMagic platform, a move that is expected to boost the company's revenue and expand its user base. The deal, made with a healthcare organization serving approximately 2,000 patients, underscores Amesite's growing presence in the healthcare software market.

This agreement is particularly important as it reflects Amesite's strategy to leverage its AI-native technology to meet the complex demands of large healthcare organizations. The announcement comes at a time when the healthcare industry is increasingly adopting AI solutions to streamline operations and improve patient care.

Company Overview

Amesite Inc. is a technology company based in Ann Arbor, Michigan, specializing in prepackaged software solutions. The company operates under the ticker symbol AMST on the Nasdaq and is classified under the SIC code 7372, which pertains to services in prepackaged software. Amesite has been active in expanding its offerings and customer base, particularly in the healthcare sector.

Details from the Filing

According to the recent SEC filing dated November 17, 2026, Amesite announced the new enterprise agreement on November 16, 2026. The filing states, "Amesite Inc. issued a press release announcing a new NurseMagic enterprise agreement with a healthcare organization serving approximately 2,000 patients." This agreement is expected to increase the company's revenue and enhance its position in the market.

Impact of the Agreement

This new contract is likely to have a broad impact on various stakeholders, including healthcare providers, patients, and Amesite's investors. For healthcare organizations, the NurseMagic platform promises to streamline documentation processes, allowing for more efficient patient care. For Amesite, this agreement is a testament to its growing reputation as a provider of innovative AI solutions in healthcare.

What's Next for Amesite?

The filing does not specify what happens next following this agreement, but it is clear that Amesite is on a growth trajectory. The company has previously secured other significant contracts, indicating a trend of increasing demand for its services. Investors and industry observers will be keen to see how this agreement translates into financial performance and further expansion in the healthcare sector.

Overall, Amesite's latest enterprise agreement not only reflects its commitment to innovation in healthcare technology but also positions it as a competitive player in the growing market for AI-driven software solutions.